Traws Pharma (TRAW) Gains from Investment Securities (2012 - 2026)
Traws Pharma (TRAW) posted quarterly Gains from Investment Securities of $159000.0 for Q1 2026, up 100.6% year-over-year from $79262.3 in Q1 2025, and up 78.65% quarter-over-quarter from $89000.0 in Q4 2025.
Traws Pharma (TRAW) Gains from Investment Securities (2012 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Gains from Investment Securities for 11 consecutive years, with $159000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 100.6% year-over-year to $159000.0; the TTM figure through Mar 2026 stood at $105000.0 (up 100.38% YoY), while the FY2025 annual figure was -$26.6 million, down 208.71% from the prior year.
- Gains from Investment Securities climbed to $159000.0 in Q1 2026 per TRAW's latest filing, from $89000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $159000.0 in Q1 2026 and bottomed at -$26.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Dec 31, 2025 | 89,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | -146,000.00 |
| Jun 30, 2025 | -146,000.00 |
| Mar 31, 2025 | -26.51 Mn |
| Mar 31, 2025 | -26.51 Mn |
| Sep 30, 2021 | -530,000.00 |
| Sep 30, 2021 | -530,000.00 |
| Jun 30, 2021 | -427,000.00 |
| Jun 30, 2021 | -427,000.00 |
| Mar 31, 2021 | 636,000.00 |
| Mar 31, 2021 | 636,000.00 |
| Dec 31, 2020 | 145,000.00 |
| Dec 31, 2020 | 145,000.00 |
| Sep 30, 2020 | -56,000.00 |
| Sep 30, 2020 | -56,000.00 |